News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Teva Pharmaceutical Industries Limited (TEVA) CFO Vows To Return To Oldie But Goodie Deal-Making Strategy


1/16/2014 8:04:39 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Teva Pharmaceutical Industries Ltd. (TEVA:US) rose to a one-year high after the maker of generic medicines said it plans to return to a deal-making strategy that made it one of the most acquisitive drug companies of the past decade. Teva’s American depositary receipts jumped 6.7 percent to $44.21 at the close in New York yesterday, the highest since May 8, 2012. The drugmaker’s Israel-traded shares gained 7.2 percent to 154.20 shekels at the close today in Tel Aviv.

Help employers find you! Check out all the jobs and post your resume.

Read at BusinessWeek

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES